The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II AIDS Malignancy Consortium trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS).
H. B. Koon
No relevant relationships to disclose
K. Honda
No relevant relationships to disclose
J. Y. Lee
No relevant relationships to disclose
A. Noy
No relevant relationships to disclose